{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:01:09Z","timestamp":1772758869397,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.phymed.2014.11.018","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T23:53:59Z","timestamp":1419033239000},"page":"231-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Berberis aristata\/Silybum marianum fixed combination (Berberol\u00ae) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3573-4760","authenticated-orcid":false,"given":"Giuseppe","family":"Derosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4285-6507","authenticated-orcid":false,"given":"Pamela","family":"Maffioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2014.11.018_bib0001","doi-asserted-by":"crossref","first-page":"44K","DOI":"10.1016\/S0002-9149(02)02969-7","article-title":"Use of combination therapy for dyslipidemia: a lipid clinic approach","volume":"90","author":"Brown","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phymed.2014.11.018_bib0002","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1194\/jlr.M600020-JLR200","article-title":"Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine","volume":"47","author":"Brusq","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phymed.2014.11.018_bib0003","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jpba.2010.12.022","article-title":"Quality control of a herbal medicinal preparation using high-performance liquid chromatographic and capillary electrophoretic methods","volume":"55","author":"Chen","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.phymed.2014.11.018_bib0004","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00394-004-0478-y","article-title":"Effects of a new low dose soy protein\/beta-sitosterol association on plasma lipid levels and oxidation","volume":"43","author":"Cicero","year":"2004","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.phymed.2014.11.018_bib0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12349-008-0011-6","article-title":"Natural sources of antidyslipidemic agents: is there an evidence-based approach for their prescription?","volume":"1","author":"Cicero","year":"2008","journal-title":"Mediterr. J. Nutr. Metab."},{"key":"10.1016\/j.phymed.2014.11.018_bib0006","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1517\/14740338.2012.705827","article-title":"Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects","volume":"11","author":"Cicero","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.phymed.2014.11.018_bib0007","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.nutres.2013.05.015","article-title":"Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects","volume":"33","author":"Cicero","year":"2013","journal-title":"Nutr. Res."},{"key":"10.1016\/j.phymed.2014.11.018_bib0008","doi-asserted-by":"crossref","first-page":"50K","DOI":"10.1016\/S0002-9149(02)02970-3","article-title":"Combination therapy for dyslipidemia: safety and regulatory considerations","volume":"90","author":"Davidson","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phymed.2014.11.018_bib0009","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ejlt.201000504","article-title":"Effects of n-3 PUFAs on insulin resistance after an oral fat load","volume":"113","author":"Derosa","year":"2011","journal-title":"Eur. J. Lipid. Sci. Technol."},{"key":"10.1016\/j.phymed.2014.11.018_bib0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jacl.2012.02.010","article-title":"n-3 PUFAs effects on post-prandial variation of metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load","volume":"6","author":"Derosa","year":"2012","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.phymed.2014.11.018_bib0011","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1517\/14712598.2012.704014","article-title":"Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials","volume":"12","author":"Derosa","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.phymed.2014.11.018_bib0012","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1185\/03007995.2012.717527","article-title":"Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study","volume":"28","author":"Derosa","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.phymed.2014.11.018_bib0013","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1517\/14712598.2013.776037","article-title":"Effects of berberine on lipid profile in subjects with low cardiovascular risk","volume":"13","author":"Derosa","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.phymed.2014.11.018_bib0014","first-page":"709","article-title":"Effects of Berberis aristata\/Silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients","volume":"27","author":"Derosa","year":"2013","journal-title":"J. Biol. Regul. Homeostatic Agents"},{"key":"10.1016\/j.phymed.2014.11.018_bib0015","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1517\/14712598.2013.832751","article-title":"Berberis aristata\/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients","volume":"13","author":"Derosa","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.phymed.2014.11.018_bib0016","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1464-5491.1999.00166.x","article-title":"A desktop guide to type 2 diabetes mellitus","volume":"16","year":"1999","journal-title":"Diabetic Med."},{"key":"10.1016\/j.phymed.2014.11.018_bib0017","unstructured":"European Pharmacopoeia 6.0, Milk Thistle Dry Extract, Refined and Standardized, pp. 2426-2427"},{"key":"10.1016\/j.phymed.2014.11.018_bib0018","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.phymed.2014.11.018_bib0019","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.phymed.2014.11.018_bib0020","first-page":"151","article-title":"World Health Organization\u2014International Society of Hypertension Guidelines for the Management of Hypertension","volume":"17","year":"1999","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phymed.2014.11.018_bib0021","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2014.11.018_bib0022","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF01225569","article-title":"Determination of total serum insulin (IRI) in insulin-treated diabetic patients","volume":"8","author":"Heding","year":"1972","journal-title":"Diabetologia"},{"key":"10.1016\/j.phymed.2014.11.018_bib0023","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ptr.1988","article-title":"The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial","volume":"20","author":"Huseini","year":"2006","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phymed.2014.11.018_bib0024","first-page":"193","article-title":"A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos)","volume":"10","author":"Kidd","year":"2005","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.phymed.2014.11.018_bib0025","first-page":"121","article-title":"Enzymatische Bestimmung des Gesamtcholesterins mit dem [Enzymatic dosage of total cholesterolemia by Greiner Selective Analyzer (GSA II)]","volume":"15","author":"Klose","year":"1978","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.phymed.2014.11.018_bib0026","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2014.11.018_bib0027","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.metabol.2008.01.037","article-title":"Combination of simvastatin with berberine improves the lipid-lowering efficacy","volume":"57","author":"Kong","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.phymed.2014.11.018_bib0028","first-page":"410","article-title":"A review of plants used in the treatment of liver disease: part 1","volume":"3","author":"Luper","year":"1998","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.phymed.2014.11.018_bib0029","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.phymed.2014.11.018_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/pds.1341","article-title":"Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present","volume":"16","author":"McClure","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.phymed.2014.11.018_bib0031","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1016\/S0021-9258(18)61433-4","article-title":"Molecular cloning and characterization of cDNA for human myeloperoxidase","volume":"262","author":"Morishita","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2014.11.018_bib0032","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jacc.2010.01.008","article-title":"High density lipoprotein and coronary heart disease: current and future therapies","volume":"55","author":"Natarajan","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phymed.2014.11.018_bib0033","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2014.11.018_bib0034","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/clinchem\/45.12.2136","article-title":"Clinical efficacy of an automated high-sensitivity C-reactive protein assay","volume":"45","author":"Rifai","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.phymed.2014.11.018_bib0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.phrs.2005.09.004","article-title":"Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats","volume":"53","author":"Sobolov\u00e1","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2014.11.018_bib0036","series-title":"Proposed International Guidelines for Biomedical Research Involving Human Subjects","year":"1982"},{"key":"10.1016\/j.phymed.2014.11.018_bib0037","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-140-8-200404200-00013","article-title":"Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians","volume":"140","author":"Vijan","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phymed.2014.11.018_bib0038","series-title":"Methods of Enzymatic Analysis","first-page":"18","article-title":"Triglycerides determination after enzymatic hydrolysis","author":"Wahlefeld","year":"1974"},{"key":"10.1016\/j.phymed.2014.11.018_bib0039","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phymed.2014.11.018_bib0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/jaoac\/86.3.476","article-title":"Method validation for determination of alkaloid content in goldenseal root powder","volume":"86","author":"Weber","year":"2003","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.phymed.2014.11.018_bib0041","series-title":"Statistical Principles in Experimental Design","author":"Winer","year":"1971"},{"key":"10.1016\/j.phymed.2014.11.018_bib0042","series-title":"Report of WHO Consultation on Obesity","article-title":"Obesity: preventing and managing the global epidemic","year":"1997"},{"key":"10.1016\/j.phymed.2014.11.018_bib0043","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1081\/DMR-120028427","article-title":"Herbal modulation of P-glycoprotein","volume":"36","author":"Zhou","year":"2004","journal-title":"Drug. Metab. Rev."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711314004000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711314004000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T17:55:31Z","timestamp":1650822931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711314004000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0944711314004000"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2014.11.018","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberis aristata\/Silybum marianum fixed combination (Berberol\u00ae) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2014.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}